Safety Shot Inc. reported Q3 2024 revenue of $110,213, up from $11,877 in Q3 2023, while posting a net loss of $11.9 million. The quarter saw increased operating expenses of $11.3 million, primarily due to marketing costs of $2.2 million, legal expenses of $2.6 million, and stock-based compensation of $5.4 million. Cost of sales was $402,399, reflecting rebranding costs for the company's dietary supplement products.The company completed a strategic transition in Q3, shifting from 12oz cans to 4oz shots and powder packs to better meet consumer needs and improve portability. The rebranding effort included taste improvements and new packaging design, though this temporarily impacted sales during the transition period. Manufacturing operations were relocated to Northern Louisiana to optimize logistics and reduce shipping costs.Looking ahead, Safety Shot is expanding its distribution network through partnerships with major retailers and convenience stores. The company maintains a strong intellectual property portfolio including five patents for its blood alcohol reduction technology. While facing several ongoing legal proceedings, management believes these will not materially impact operations. The company held $1.36 million in cash as of September 30, 2024.

Safety Shot Inc. reported Q3 2024 revenue of $110,213, up from $11,877 in Q3 2023, while posting a net loss of $11.9 million. The quarter saw increased operating expenses of $11.3 million, primarily due to marketing costs of $2.2 million, legal expenses of $2.6 million, and stock-based compensation of $5.4 million. Cost of sales was $402,399, reflecting rebranding costs for the company's dietary supplement products.The company completed a strategic transition in Q3, shifting from 12oz cans to 4oz shots and powder packs to better meet consumer needs and improve portability. The rebranding effort included taste improvements and new packaging design, though this temporarily impacted sales during the transition period. Manufacturing operations were relocated to Northern Louisiana to optimize logistics and reduce shipping costs.Looking ahead, Safety Shot is expanding its distribution network through partnerships with major retailers and convenience stores. The company maintains a strong intellectual property portfolio including five patents for its blood alcohol reduction technology. While facing several ongoing legal proceedings, management believes these will not materially impact operations. The company held $1.36 million in cash as of September 30, 2024.